A citation-based method for searching scientific literature

Tamara Seredenina, Ruth Luthi-Carter. Neurobiol Dis 2012
Times Cited: 102







List of co-cited articles
1443 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Regional and cellular gene expression changes in human Huntington's disease brain.
Angela Hodges, Andrew D Strand, Aaron K Aragaki, Alexandre Kuhn, Thierry Sengstag, Gareth Hughes, Lyn A Elliston, Cathy Hartog, Darlene R Goldstein, Doris Thu,[...]. Hum Mol Genet 2006
540
48

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
Alexandre Kuhn, Darlene R Goldstein, Angela Hodges, Andrew D Strand, Thierry Sengstag, Charles Kooperberg, Kristina Becanovic, Mahmoud A Pouladi, Kirupa Sathasivam, Jang-Ho J Cha,[...]. Hum Mol Genet 2007
255
36

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
30

Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.
Peter Langfelder, Jeffrey P Cantle, Doxa Chatzopoulou, Nan Wang, Fuying Gao, Ismael Al-Ramahi, Xiao-Hong Lu, Eliana Marisa Ramos, Karla El-Zein, Yining Zhao,[...]. Nat Neurosci 2016
203
30

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.
R Luthi-Carter, A Strand, N L Peters, S M Solano, Z R Hollingsworth, A S Menon, A S Frey, B S Spektor, E B Penney, G Schilling,[...]. Hum Mol Genet 2000
568
22

Targeting H3K4 trimethylation in Huntington disease.
Malini Vashishtha, Christopher W Ng, Ferah Yildirim, Theresa A Gipson, Ian H Kratter, Laszlo Bodai, Wan Song, Alice Lau, Adam Labadorf, Annie Vogel-Ciernia,[...]. Proc Natl Acad Sci U S A 2013
101
22

Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models.
Ghazaleh Sadri-Vakili, Bérengère Bouzou, Caroline L Benn, Mee-Ohk Kim, Prianka Chawla, Ryan P Overland, Kelly E Glajch, Eva Xia, Zhihua Qiu, Steven M Hersch,[...]. Hum Mol Genet 2007
158
21

Extensive changes in DNA methylation are associated with expression of mutant huntingtin.
Christopher W Ng, Ferah Yildirim, Yoon Sing Yap, Simona Dalin, Bryan J Matthews, Patricio J Velez, Adam Labadorf, David E Housman, Ernest Fraenkel. Proc Natl Acad Sci U S A 2013
100
20

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
964
20

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
19

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.
J S Steffan, A Kazantsev, O Spasic-Boskovic, M Greenwald, Y Z Zhu, H Gohler, E E Wanker, G P Bates, D E Housman, L M Thompson. Proc Natl Acad Sci U S A 2000
795
19

Molecular mechanisms and potential therapeutical targets in Huntington's disease.
Chiara Zuccato, Marta Valenza, Elena Cattaneo. Physiol Rev 2010
572
18

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.
F C Nucifora , M Sasaki, M F Peters, H Huang, J K Cooper, M Yamada, H Takahashi, S Tsuji, J Troncoso, V L Dawson,[...]. Science 2001
823
18

Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease.
Karen N McFarland, Sudeshna Das, Ting Ting Sun, Dmitri Leyfer, Eva Xia, Gavin R Sangrey, Alexandre Kuhn, Ruth Luthi-Carter, Timothy W Clark, Ghazaleh Sadri-Vakili,[...]. PLoS One 2012
59
30

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
J S Steffan, L Bodai, J Pallos, M Poelman, A McCampbell, B L Apostol, A Kazantsev, E Schmidt, Y Z Zhu, M Greenwald,[...]. Nature 2001
912
18


Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.
Ruth Luthi-Carter, Sarah A Hanson, Andrew D Strand, Donald A Bergstrom, Wanjoo Chun, Nikki L Peters, Annette M Woods, Edmond Y Chan, Charles Kooperberg, Dimitri Krainc,[...]. Hum Mol Genet 2002
297
17

The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.
Elizabeth A Thomas, Giovanni Coppola, Paula A Desplats, Bin Tang, Elisabetta Soragni, Ryan Burnett, Fuying Gao, Kelsey M Fitzgerald, Jenna F Borok, David Herman,[...]. Proc Natl Acad Sci U S A 2008
214
16

Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.
Caroline L Benn, Tingting Sun, Ghazaleh Sadri-Vakili, Karen N McFarland, Derek P DiRocco, George J Yohrling, Timothy W Clark, Bérengère Bouzou, Jang-Ho J Cha. J Neurosci 2008
136
15

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
Chiara Zuccato, Marzia Tartari, Andrea Crotti, Donato Goffredo, Marta Valenza, Luciano Conti, Tiziana Cataudella, Blair R Leavitt, Michael R Hayden, Tõnis Timmusk,[...]. Nat Genet 2003
662
14

Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.
Robert J Ferrante, James K Kubilus, Junghee Lee, Hoon Ryu, Ayshe Beesen, Birgit Zucker, Karen Smith, Neil W Kowall, Rajiv R Ratan, Ruth Luthi-Carter,[...]. J Neurosci 2003
492
14

Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease.
Luis M Valor, Deisy Guiretti, Jose P Lopez-Atalaya, Angel Barco. J Neurosci 2013
48
29

ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.
Hoon Ryu, Junghee Lee, Sean W Hagerty, Byoung Yul Soh, Sara E McAlpin, Kerry A Cormier, Karen M Smith, Robert J Ferrante. Proc Natl Acad Sci U S A 2006
217
13

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
13

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.
Gabriella Gardian, Susan E Browne, Dong-Kug Choi, Peter Klivenyi, Jason Gregorio, James K Kubilus, Hoon Ryu, Brett Langley, Rajiv R Ratan, Robert J Ferrante,[...]. J Biol Chem 2005
338
13

Huntingtin facilitates polycomb repressive complex 2.
Ihn Sik Seong, Juliana M Woda, Ji-Joon Song, Alejandro Lloret, Priyanka D Abeyrathne, Caroline J Woo, Gillian Gregory, Jong-Min Lee, Vanessa C Wheeler, Thomas Walz,[...]. Hum Mol Genet 2010
117
13

RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression.
Adam Labadorf, Andrew G Hoss, Valentina Lagomarsino, Jeanne C Latourelle, Tiffany C Hadzi, Joli Bregu, Marcy E MacDonald, James F Gusella, Jiang-Fan Chen, Schahram Akbarian,[...]. PLoS One 2015
99
13

Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.
Mayada Achour, Stéphanie Le Gras, Céline Keime, Frédéric Parmentier, François-Xavier Lejeune, Anne-Laurence Boutillier, Christian Néri, Irwin Davidson, Karine Merienne. Hum Mol Genet 2015
52
25

Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
Anthone W Dunah, Hyunkyung Jeong, April Griffin, Yong-Man Kim, David G Standaert, Steven M Hersch, M Maral Mouradian, Anne B Young, Naoko Tanese, Dimitri Krainc. Science 2002
538
12

Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.
Paula A Desplats, Kristi E Kass, Tim Gilmartin, Gregg D Stanwood, Elliott L Woodward, Steven R Head, J Gregor Sutcliffe, Elizabeth A Thomas. J Neurochem 2006
105
12

The Biology of Huntingtin.
Frédéric Saudou, Sandrine Humbert. Neuron 2016
418
12

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
11

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.
Kirupa Sathasivam, Andreas Neueder, Theresa A Gipson, Christian Landles, Agnesska C Benjamin, Marie K Bondulich, Donna L Smith, Richard L M Faull, Raymund A C Roos, David Howland,[...]. Proc Natl Acad Sci U S A 2013
285
11

Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
A Giralt, M Puigdellívol, O Carretón, P Paoletti, J Valero, A Parra-Damas, C A Saura, J Alberch, S Ginés. Hum Mol Genet 2012
103
11

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
945
11

Huntington's disease.
Francis O Walker. Lancet 2007
11

Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease.
Fengli Wang, Yeran Yang, Xiwen Lin, Jiu-Qiang Wang, Yong-Sheng Wu, Wenjuan Xie, Dandan Wang, Shu Zhu, You-Qi Liao, Qinmiao Sun,[...]. Hum Mol Genet 2013
90
12

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.
Emma Hockly, Victoria M Richon, Benjamin Woodman, Donna L Smith, Xianbo Zhou, Eddie Rosa, Kirupa Sathasivam, Shabnam Ghazi-Noori, Amarbirpal Mahal, Philip A S Lowden,[...]. Proc Natl Acad Sci U S A 2003
635
11

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
341
11



HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation.
Haiqun Jia, Charles D Morris, Roy M Williams, Jeanne F Loring, Elizabeth A Thomas. Proc Natl Acad Sci U S A 2015
68
16

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
564
11


Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.
F Trettel, D Rigamonti, P Hilditch-Maguire, V C Wheeler, A H Sharp, F Persichetti, E Cattaneo, M E MacDonald. Hum Mol Genet 2000
487
10

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
10

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
449
10

Normal huntingtin function: an alternative approach to Huntington's disease.
Elena Cattaneo, Chiara Zuccato, Marzia Tartari. Nat Rev Neurosci 2005
454
10

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.